Table 2.
Comparison of radiographic and clinical parameters between group A and B
| Category | Group A acute-to-chronic SDH (group A) |
Group B conventional CSDH (group B) |
p-value OR 95% CI |
|
|---|---|---|---|---|
| Clinical performance | ||||
| mRS (median) | 2 | 2 | 0.58 | |
| DOC | 12/41 (29.3%) | 32/282 (11.3%) |
0.002 3 1.5-7 |
|
| New motor deficit | 11/41 (26.8%) | 133/282 (47.2%) |
0.014 0.4 0.2–0.9 |
|
| Epileptic seizure | 2/41 (4.9%) | 15/282 (5.4%) | 1 | |
| Radiographic parameters | ||||
| Midline shift in mm (mean) | 8.8 (SD 4.8) | 8.5 (SD 4.6) | 0.8 | |
| Hematoma width in mm (mean) | 15.5 (SD 4.2) | 22.4 (SD 6.6) | < 0.001 | |
| Frontal | 41/41 (100%) | 277/282 (98.2%) | 1 | |
| Parietal | 38/41 (92.7%) | 256/282 (90.8%) | 1 | |
| Temporal | 36/41 (87.8%) | 143/282 (50.7%) |
< 0.001 7 2.7–18.4 |
|
| Occipital | 19/41 (46.3%) | 56/282 (19.9%) |
< 0.001 3.5 1.8–6.9 |
|
| Entire hemisphere | 19/41 (46.3%) | 50/282 (17.7%) |
< 0.001 4 2–8 |
|
| Outcome parameters | ||||
| Death | 3/41 (7.3%) | 18/282 (6.4%) | 0.738 | |
| Recurrence | 6/41 (14.6%) | 56/282 (19.9%) | 0.427 |